Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51.1M
-
Number of holders
-
399
-
Total shares
-
45.4M
-
Shares change
-
-1.28M
-
Total reported value, excl. options
-
$5.14B
-
Value change
-
-$151M
-
Put/Call ratio
-
0.34
-
Number of buys
-
170
-
Number of sells
-
-184
-
Price
-
$113.18
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) as of Q4 2018
409 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock as of Q4 2018.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) has 399 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.4M shares
of 51.1M outstanding shares and own 88.91% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (5.28M shares), BlackRock Inc. (4.53M shares), RENAISSANCE TECHNOLOGIES LLC (1.88M shares), FMR LLC (1.81M shares), AQR CAPITAL MANAGEMENT LLC (1.77M shares), WELLS FARGO & COMPANY/MN (1.47M shares), STATE STREET CORP (1.14M shares), FIRST TRUST ADVISORS LP (1.1M shares), TimesSquare Capital Management, LLC (1.03M shares), and ARIEL INVESTMENTS, LLC (988K shares).
This table shows the top 399 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.